Compare BOOM & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BOOM | NYXH |
|---|---|---|
| Founded | 1965 | 2009 |
| Country | United States | Belgium |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 153.2M | 165.0M |
| IPO Year | 1995 | 2021 |
| Metric | BOOM | NYXH |
|---|---|---|
| Price | $6.42 | $1.54 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $8.50 | ★ $9.33 |
| AVG Volume (30 Days) | 78.0K | ★ 247.6K |
| Earning Date | 04-30-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 89.02 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $609,840,000.00 | N/A |
| Revenue This Year | N/A | $213.98 |
| Revenue Next Year | $8.55 | $126.25 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.69 | $1.26 |
| 52 Week High | $9.20 | $6.87 |
| Indicator | BOOM | NYXH |
|---|---|---|
| Relative Strength Index (RSI) | 43.44 | 44.06 |
| Support Level | $6.08 | $1.49 |
| Resistance Level | $6.76 | $1.70 |
| Average True Range (ATR) | 0.30 | 0.08 |
| MACD | -0.05 | -0.01 |
| Stochastic Oscillator | 21.66 | 8.33 |
DMC Global Inc operates a diversified family of technical product and process businesses serving the energy, industrial and infrastructure markets. Its business is organized into three segments: Arcadia, DynaEnergetics, and NobelClad. Arcadia Products supplies architectural building products, including exterior and interior framing systems, windows, urtain walls, storefronts etc to the commercial construction market. NobelClad is involved in the production of explosion-welded clad metal plates for use in the construction of corrosion-resistant industrial processing equipment and specialized transition joints. DynaEnergetics driver, designs manufactures and distributes products utilized by the oil and gas industry principally for the perforation of oil and gas wells.
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.